{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:03:18Z","timestamp":1740106998373,"version":"3.37.3"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:00:00Z","timestamp":1733961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:00:00Z","timestamp":1733961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s00520-024-09058-1","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T05:32:15Z","timestamp":1733981535000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Organs in plain sight\u2014parotid gland doses in short-course palliative whole-brain radiotherapy"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-5821-3248","authenticated-orcid":false,"given":"Maheshkumar N.","family":"Upasani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prashantkumar","family":"Shinde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rameshwar","family":"Veer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,12]]},"reference":[{"issue":"1\u20136","key":"9058_CR1","doi-asserted-by":"publisher","first-page":"v","DOI":"10.1016\/j.nec.2010.08.007","volume":"22","author":"BD Fox","year":"2011","unstructured":"Fox BD, Cheung VJ, Patel AJ et al (2011) Epidemiology of metastatic brain tumors. Neurosurg Clin N Am 22(1\u20136):v. https:\/\/doi.org\/10.1016\/j.nec.2010.08.007","journal-title":"Neurosurg Clin N Am"},{"key":"9058_CR2","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1093\/neuonc\/nos152","volume":"14","author":"FG Davis","year":"2012","unstructured":"Davis FG, Dolecek TA, McCarthy BJ, Villano JL (2012) Toward determining the lifetime occurrence of metastatic brain tumors estimated from 2007 United States cancer incidence data. Neuro Oncol 14:1171\u20131177. https:\/\/doi.org\/10.1093\/neuonc\/nos152","journal-title":"Neuro Oncol"},{"key":"9058_CR3","doi-asserted-by":"publisher","unstructured":"Tsao MN, Xu W, Wong RK, et al (2018) Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases. Cochrane Database Syst Rev 1:CD003869. https:\/\/doi.org\/10.1002\/14651858.CD003869.pub4","DOI":"10.1002\/14651858.CD003869.pub4"},{"key":"9058_CR4","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.prro.2011.12.004","volume":"2","author":"MN Tsao","year":"2012","unstructured":"Tsao MN, Rades D, Wirth A et al (2012) Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): an American Society for Radiation Oncology evidence-based guideline. Pract Radiat Oncol 2:210\u2013225. https:\/\/doi.org\/10.1016\/j.prro.2011.12.004","journal-title":"Pract Radiat Oncol"},{"key":"9058_CR5","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.radonc.2011.08.041","volume":"102","author":"S Scoccianti","year":"2012","unstructured":"Scoccianti S, Ricardi U (2012) Treatment of brain metastases: review of phase III randomized controlled trials. Radiother Oncol 102:168\u2013179. https:\/\/doi.org\/10.1016\/j.radonc.2011.08.041","journal-title":"Radiother Oncol"},{"key":"9058_CR6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/0167-8140(93)90091-l","volume":"26","author":"C Haie-Meder","year":"1993","unstructured":"Haie-Meder C, Pellae-Cosset B, Laplanche A et al (1993) Results of a randomized clinical trial comparing two radiation schedules in the palliative treatment of brain metastases. Radiother Oncol 26:111\u2013116. https:\/\/doi.org\/10.1016\/0167-8140(93)90091-l","journal-title":"Radiother Oncol"},{"key":"9058_CR7","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.radonc.2008.05.020","volume":"88","author":"P Davey","year":"2008","unstructured":"Davey P, Hoegler D, Ennis M, Smith J (2008) A phase III study of accelerated versus conventional hypofractionated whole brain irradiation in patients of good performance status with brain metastases not suitable for surgical excision. Radiother Oncol 88:173\u2013176. https:\/\/doi.org\/10.1016\/j.radonc.2008.05.020","journal-title":"Radiother Oncol"},{"key":"9058_CR8","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.clon.2010.05.022","volume":"22","author":"JP Agarwal","year":"2010","unstructured":"Agarwal JP, Wadasadawala T, Munshi A et al (2010) Validation of recursive partitioning analysis classification in patients with brain metastases from non-small cell lung cancer treated with short-course accelerated radiotherapy. Clin Oncol (R Coll Radiol) 22:837\u2013843. https:\/\/doi.org\/10.1016\/j.clon.2010.05.022","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"9058_CR9","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/s0360-3016(99)00247-3","volume":"45","author":"A Eisbruch","year":"1999","unstructured":"Eisbruch A, Ten Haken RK, Kim HM et al (1999) Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 45:577\u2013587. https:\/\/doi.org\/10.1016\/s0360-3016(99)00247-3","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"9058_CR10","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s11547-014-0436-6","volume":"120","author":"M Trignani","year":"2015","unstructured":"Trignani M, Genovesi D, Vinciguerra A et al (2015) Parotid glands in whole-brain radiotherapy: 2D versus 3D technique for no sparing or sparing. Radiol Med 120:324\u2013328. https:\/\/doi.org\/10.1007\/s11547-014-0436-6","journal-title":"Radiol Med"},{"key":"9058_CR11","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.radonc.2010.12.013","volume":"98","author":"OK Noh","year":"2011","unstructured":"Noh OK, Chun M, Nam SS et al (2011) Parotid gland as a risk organ in whole brain radiotherapy. Radiother Oncol 98:223\u2013226. https:\/\/doi.org\/10.1016\/j.radonc.2010.12.013","journal-title":"Radiother Oncol"},{"key":"9058_CR12","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1001\/jamaoncol.2018.4951","volume":"5","author":"K Wang","year":"2019","unstructured":"Wang K, Pearlstein KA, Moon DH et al (2019) Assessment of risk of xerostomia after whole-brain radiation therapy and association with parotid dose. JAMA Oncol 5:221\u2013228. https:\/\/doi.org\/10.1001\/jamaoncol.2018.4951","journal-title":"JAMA Oncol"},{"key":"9058_CR13","doi-asserted-by":"publisher","first-page":"e1217","DOI":"10.7759\/cureus.1217","volume":"9","author":"A Orton","year":"2017","unstructured":"Orton A, Gordon J, Vigh T et al (2017) Differences in parotid dosimetry and expected normal tissue complication probabilities in whole brain radiation plans covering C1 versus C2. Cureus 9:e1217. https:\/\/doi.org\/10.7759\/cureus.1217","journal-title":"Cureus"},{"key":"9058_CR14","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.ijrobp.2008.03.068","volume":"73","author":"C Ortholan","year":"2009","unstructured":"Ortholan C, Chamorey E, Benezery K et al (2009) Modeling of salivary production recovery after radiotherapy using mixed models: determination of optimal dose constraint for IMRT planning and construction of convenient tools to predict salivary function. Int J Radiat Oncol Biol Phys 73:178\u201386. https:\/\/doi.org\/10.1016\/j.ijrobp.2008.03.068","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"9058_CR15","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.ijrobp.2009.09.040","volume":"76","author":"SM Bentzen","year":"2010","unstructured":"Bentzen SM, Constine LS, Deasy JO et al (2010) Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues. Int J Radiat Oncol Biol Phys 76:S3-9. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.09.040","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"9058_CR16","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1016\/j.ijrobp.2009.06.090","volume":"76","author":"JO Deasy","year":"2010","unstructured":"Deasy JO, Moiseenko V, Marks L et al (2010) Radiotherapy dose-volume effects on salivary gland function. Int J Radiat Oncol Biol Phys 76:S58-63. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.06.090","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"9058_CR17","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S0140-6736(18)32779-X","volume":"393","author":"ML Gillison","year":"2019","unstructured":"Gillison ML, Trotti AM, Harris J et al (2019) Radiotherapy plus cetuximab or cisplatin for human papillomavirus (HPV)-positive oropharyngeal cancer: a randomized, multicentre, non-inferiority clinical trial. Lancet 393:40\u201350. https:\/\/doi.org\/10.1016\/S0140-6736(18)32779-X","journal-title":"Lancet"},{"key":"9058_CR18","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/S1470-2045(11)70303-5","volume":"13","author":"NY Lee","year":"2012","unstructured":"Lee NY, Zhang Q, Pfister DG et al (2012) Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial. Lancet Oncol 13:172\u201380. https:\/\/doi.org\/10.1016\/S1470-2045(11)70303-5","journal-title":"Lancet Oncol"},{"key":"9058_CR19","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/s0167-8140(01)00427-3","volume":"61","author":"FR Burlage","year":"2001","unstructured":"Burlage FR, Coppes RP, Meertens H et al (2001) Parotid and submandibular\/sublingual salivary flow during high dose radiotherapy. Radiother Oncol 61:271\u2013274. https:\/\/doi.org\/10.1016\/s0167-8140(01)00427-3","journal-title":"Radiother Oncol"},{"key":"9058_CR20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13014-021-01786-6","volume":"16","author":"P Mavroidis","year":"2021","unstructured":"Mavroidis P, Pearlstein KA, Moon DH et al (2021) NTCP modeling and dose-volume correlations for acute xerostomia and dry eye after whole brain radiation. Radiat Oncol 16:56. https:\/\/doi.org\/10.1186\/s13014-021-01786-6","journal-title":"Radiat Oncol"},{"key":"9058_CR21","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S1470-2045(09)70101-9","volume":"10","author":"C Le P\u00e9choux","year":"2009","unstructured":"Le P\u00e9choux C, Dunant A, Senan S et al (2009) Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99\u201301, EORTC 22003\u201308004, RTOG 0212, and IFCT 99\u201301): a randomised clinical trial. Lancet Oncol 10:467\u201374. https:\/\/doi.org\/10.1016\/S1470-2045(09)70101-9","journal-title":"Lancet Oncol"},{"key":"9058_CR22","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.meddos.2017.02.006","volume":"42","author":"C-C Wu","year":"2017","unstructured":"Wu C-C, Wuu Y-R, Jani A et al (2017) Whole-brain irradiation field design: a comparison of parotid dose. Med Dosim 42:145\u2013149. https:\/\/doi.org\/10.1016\/j.meddos.2017.02.006","journal-title":"Med Dosim"},{"key":"9058_CR23","doi-asserted-by":"publisher","first-page":"36","DOI":"10.12701\/yujm.2019.00087","volume":"36","author":"J Park","year":"2019","unstructured":"Park J, Park JW, Yea JW (2019) Non-coplanar whole brain radiotherapy is an effective modality for parotid sparing. Yeungnam Univ J Med 36:36\u201342. https:\/\/doi.org\/10.12701\/yujm.2019.00087","journal-title":"Yeungnam Univ J Med"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-09058-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-024-09058-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-09058-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T09:42:04Z","timestamp":1737366124000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-024-09058-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,12]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["9058"],"URL":"https:\/\/doi.org\/10.1007\/s00520-024-09058-1","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"type":"print","value":"0941-4355"},{"type":"electronic","value":"1433-7339"}],"subject":[],"published":{"date-parts":[[2024,12,12]]},"assertion":[{"value":"17 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is a retrospective study. The National Cancer Institute, Nagpur Ethics Committee, has reviewed and approved it on December 18, 2021\u2014Ref No.: NCI\/EC\/2018\/022\/12\/2021\u2014ensuring that this was in adherence to the principles outlined in the Declaration of Helsinki and in accordance with the highest ethical standards and national and international regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors affirm that human research participants provided informed consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21"}}